We have read dozens of articles about hedge funds and hedge fund advertising over the last few weeks. None of them were 100% accurate and most of them were filled with inaccuracies.
Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don't have to imagine it.
In the financial world, there are plenty of indicators market participants can use to track publicly traded companies. A couple of the most useful are hedge fund and insider trading sentiment.
"Making every patient count" is a catchy phrase that is perhaps most meaningful for biotech companies like NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) who are in the business of developing orphan drugs.
Investments in biotechnology by the average investor tend to deliver hit or miss returns over time. Since inception, the SPDR S&P Biotech ETF has delivered double-digit returns.